Respiratory Infections News

Researchers found an association between region of birth and time to diagnosis among foreign-born people in the U.S. with tuberculosis, suggesting that where a person was born may predict progression from latent TB to TB disease, they said.

A study conducted in eight countries with a middle or high burden of tuberculosis found that at least 10% of household contacts can be classified as resistant to TB infection, including those with high exposure.

A 4-month daily regimen of rifapentine and moxifloxacin was noninferior to the standard 6-month regimen for tuberculosis treatment among people with HIV enrolled in a phase 3 clinical trial, researchers reported at CROI.

Several vaccines against COVID-19 have been shown to be highly efficacious and seem close to licensure — a development made in less than 1 year.

In less than a year, scientists were able to develop several efficacious vaccines against COVID-19.

Globally, millions of people affected by tuberculosis are being diagnosed and treated with outdated tools, according to a new report from the Stop TB Partnership.

Tuberculosis screening and clinical surveillance are needed for patients prescribed methotrexate — especially alongside corticosteroids or other immunosuppressants — in tuberculosis-endemic areas, according to a speaker at ACR Convergence.

In a study conducted at three sites in South Africa, combination therapy with bedaquiline, pretomanid and linezolid led to favorable outcomes in most patients with highly drug-resistant tuberculosis.

In a study conducted at three sites in South Africa, combination therapy with bedaquiline, pretomanid and linezolid led to favorable outcomes in most patients with highly drug-resistant tuberculosis.

The CDC and National Tuberculosis Controllers Association, or NTCA, has published updated recommendations for latent tuberculosis, or LTBI, in the MMWR for the first time since 2000.